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Identifying causative variants in cis-regulatory elements (CRE) in neurodevelopmental dis-
orders has proven challenging. We have used in vivo functional analyses to categorize rigor-
ously filtered CRE variants in a clinical cohort that is plausibly enriched for causative CRE
mutations: 48 unrelated males with a family history consistent with X-linked intellectual dis-
ability (XLID) in whom no detectable cause could be identified in the coding regions of the X
chromosome (chrX). Targeted sequencing of all chrX CRE identified six rare variants in five
affected individuals that altered conserved bases in CRE targeting known XLID genes and
segregated appropriately in families. Two of these variants, FMR1CRE and TENM1CRE,
showed consistent site- and stage-specific differences of enhancer function in the develop-
ing zebrafish brain using dual-color fluorescent reporter assay. Mouse models were created
for both variants. In male mice Fmr1CRE induced alterations in neurodevelopmental Fmr1
expression, olfactory behavior and neurophysiological indicators of FMRP function. The
absence of another likely causative variant on whole genome sequencing further supported
FMR1CRE as the likely basis of the XLID in this family. Tenm1CRE mice showed no pheno-
typic anomalies. Following the release of gnomAD 2.1, reanalysis showed that TENM1CRE
exceeded the maximum plausible population frequency of a XLID causative allele. Assign-
ing causative status to any ultra-rare CRE variant remains problematic and requires
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disease-relevant in vivo functional data from multiple sources. The sequential and bespoke
nature of such analyses renders them time-consuming and challenging to scale for routine
clinical use.
Introduction
Cis-regulatory elements (CRE; encompassing enhancers and repressors) are genomic
sequences that control transcriptional activity of one or more genes on the same chromosome
via sequence-specific interaction of the DNA with proteins and/or RNA. CRE can be predicted
using comparative genomics [1], transcriptional characteristics [2], patterns of histone modifi-
cations and protein association [3], patterns of accessible chromatin [4] and direct interactions
with promoters [5]. Although estimates of the number of CRE in the human genome vary
with each prediction method, functional ENCODE data has been interpreted as identifying at
least 400,000 putative human enhancers [6]. Disrupted CRE function as a cause of Mendelian
disease was first recognized via the loss or gain of regulatory function resulting from structural
chromosome anomalies such as deletion or translocation [7–10]. However, the identification
of disease-associated single nucleotide variants within individual CRE has been complicated
by several factors. CRE can function over large genomic intervals and the targeted gene may
not be the closest gene. CRE mostly exist in the non-coding parts of the human genome where
our current understanding of mutation consequence is very incomplete compared to the cod-
ing region.
Developmental disorders (DD) are a diverse group of conditions caused by perturbations
of embryogenesis or early brain development. The combination of massively parallel sequenc-
ing technologies and family-based analyses has proven very effective in identifying the genes
and mechanisms causing severe developmental disorders in humans. DD are primarily geneti-
cally determined with a high proportion of causative coding region variants arising as de novo
mutations (DNM) [11]. The genomic intervals encompassing known DD causative genes are
commonly enriched in highly conserved CRE [12]. DNM enrichment is also evident in evolu-
tionarily conserved, brain-active CRE in severe DD at a cohort level [13] but the confident
assignment of variants as causative in affected individuals is not yet possible [14].
We have previously identified all likely CRE on the human X chromosome and assigned
these to their target genes [15]. Here we have sequenced all of these CRE in 48 individuals with
intellectual disability (ID) and a family history indicating that the ID is X-linked (XLID). Each
affected individual had previously had a negative screen for likely causative mutations in all
coding exons on the X chromosome [16]. Following strict filtering, six rare variants in CRE
predicted to control known XLID genes were tested in vivo using zebrafish and mouse models
to classify their diagnostic potential. After these studies and reanalysis of the population allele
frequencies following the release of gnomAD 2.1 data, only one CRE variant, causing a com-
plex dysregulation of the gene FMR1(FMRP translational regulator 1), could be considered as
likely causative in a single family.
Materials and methods
Cohort selection
Genomic DNA samples from 48 individuals (probands) with moderate-to-severe intellectual
disability (ID) were used in this study. Research ethics review and approval was granted by the
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UK Multicentre Research Ethics Committee in Cambridge with approval number 03/0/014.
Written consent was obtained from the parents or guardians of each affected individual
included in the study. Each individual is assumed to have X-linked recessive form of ID on the
basis of positive family history: three or more cases of ID in males only, predominant sparing
of carrier females and no evidence of male-to-male transmission of the disease. A clinical
geneticist had assessed the individuals and the cause of the ID was unknown. The severity of
the disease was categorized using DSM–IV or ICD-10 classifications (profound mental retar-
dation was classified as severe). The affected individuals had previously been tested negative by
routine diagnostic approaches (i.e., CGH microarray analysis at 500 kb resolution, fragile X
[MIM 300624], methylation status of Prader Willi [MIM 176270]/Angelman syndrome [MIM
105830]). In addition, all 48 individuals have been screened within a previous study [16] for
coding variants on the X chromosome likely to lead to disease and such variants had not been
found. The whole genome sequencing of individual S3 was performed and analyzed within the
UK National Health Service as part of a large-scale clinical implementation study led by one of
the authors (FLR) [17].
Targeted capture design and sequencing
A comprehensive list of coordinates of all exonic and conserved regulatory elements from
chrX used to design a customized capture library (Roche, NimbleGen) is provided in S1
Table. Library preparation, pre- and post-capture multiplexing were performed using the Seq-
Cap EZ Choice XL kit (Roche NimbleGen) and TruSeq index barcodes (Illumina) were used
according to the manufacturer’s instructions. 4 different DNA samples were pooled for pre-
capture multiplexing and 4 post-captured libraries were combined. Paired-end sequenced per-
formed on a single lane of a HiSeq-2000 instrument (Illumina). In total 16 different DNA sam-
ples were sequenced in a single lane of a HiSeq-2000 and 4 lanes were used to sequence all 48
DNA samples.
Read mapping, variant analysis and enhancer selection
Following quality control with FastQC, reads were mapped to the GRCh37 version of the
human reference genome using BWA [18]. Variants were called using GATK [19] according
to its recommended best practice pipeline. 40,699 variants remained after filtering out variants
that failed GATK’s variant quality score recalibration. These variants were subsequently com-
pared to dbSNP v137 to filter out common variants. Any variant with one of the following han-
dles in dbSNP (1000GENOMES, CSHL-HAPMAP, EGP_SNPS, NHLBI-ESP,
PGA-UW-FHCRC) were excluded where the variant’s reported minor allele frequency was
greater than 0.01 or the minor allele was observed in at least two samples. The remaining 9,577
chrX variants were then annotated with SnpEff [20] to determine their predicted effects on
genes.
To determine the best candidates for experimental validations, the variants were ranked
based on extreme evolutionary conservation. Using Multiple Sequence Alignments from 45
vertebrate species against the Human genome (UCSC genome browser), mutations were
retained if the reference human allele was conserved in at least 90% of the species, and then
sorted by decreasing conservation depth. Top variants were then manually evaluated using
biochemical signals from the ENCODE project (H3K4me1, H3K4me3, H3K27ac, DNase1 sen-
sitivity), and based on the association to target genes known to be responsible for XLID or
functionally related to brain development, leading to a final selection of 31 candidate variants
(S2 Table in S1 File). Target genes for each of the CRE harboring the variants were assigned as
described previously [15].
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Motif search on CRE element was performed on a 40bp window around the mutated base
for both human and mouse sequences using the FIMO software from the MEME suite [21].
The motif databases used for the search were Jaspar Core 2018 for vertebrates and Uniprobe
mouse motifs as downloaded from the MEME website. Motifs with a p-value of 0.001 or lower
that were present uniquely in either the WT or the mutant sequences are reported.
Animal study licenses
All mouse and zebrafish experiments were approved by The University of Edinburgh ethical
committee and performed under UK Home Office license number PIL 60/12763, 70/25905,
I655D57B6, PA3527EC3 and 1724D1B2C; PPL 60/4418, 60/4424, IFC719EAD and 60/4290.
Transgenic zebrafish, In Situ Hybridization (ISH) and morphant
generation
The wild-type and mutant versions of the six variants documented in Fig 1 and Table 1 were
analyzed for their regulatory activities in dual color enhancer-reporter transgenic assays in
zebrafish embryos [22]. The sequences of the primers used in generating the constructs
Fig 1. Project summary and XLID-associated regulatory variants and their predicted target genes. (A) A diagrammatic summary of the experimental pipeline
followed in this paper. (B) Schematic showing the genomic region of the six genomic variants in the five probands (S19, S24, S43, S3 and S31) indicating the location
of the XLID-associated CRE variants along with their predicted target genes indicated in red, genomic coordinates from h19/GRCh37 genome build. The variants
highlighted by grey box were used to make mouse models.
https://doi.org/10.1371/journal.pone.0256181.g001
Table 1. Allele frequencies of the six variants tested in the dual-color reporter transgenic assays.
Proband Variant Target Gene Alleles Total Alleles Hemizygotes Allele Frequency�
S3 X-146875009-C-T FMR1 0 NA 0 NA
S19 X-25260740-A-G POLA1 PCYT1B 0 21967 0 NA
S24 X-124269322-G-A TENM1 1 21962 0 0.00004553
S24 X-136183176-G-A ARHGEF6 7 21979 1 0.0003185
S31 X-147866225-C-A AFF2 9 22020 3 0.0004319
S43 X-45375111-C-G KDM6A 0 NA 0 NA
�Popmax Filtering AF (95% confidence).
https://doi.org/10.1371/journal.pone.0256181.t001
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utilized in the assay are listed in S3 Table in S1 File. The number of independent lines ana-
lyzed for each enhancer and their expression sites is summarized in Table 2. The transgenic
F1 embryos were processed for imaging as described [22]. The images were taken on a Nikon
A1R confocal microscope and processed using A1R analysis software.
A zebrafish six3 antisense morpholino oligonucleotide (Six3AMO) was obtained from
Gene Tools, LLC, with the following sequence: 5´ GCTCTAAAGGAGACCTGAAAACCAT 3´.
This morpholino has sequence complementary to the highly conserved sequences around the
translation initiation codon of both six3a and six3b, and hence inhibits the function of both
zebrafish six3 genes [23]. As control we used the Gene Tools LLC standard negative control
morpholino: 5´ CCTCTTACCTCAGTTACAATTTATA 3´. The morpholinos were injected into
1 to 2-cell stage of at least 100 embryos to deliver an approximate amount of 2.5 ng per
embryo.
RNA in situ hybridization on fish embryos was performed as previously [24]. The
sequences of primers used for synthesis of specific probes are listed in (S3 Table in S1 File).
Generation of transgenic mice and embryo ISH
CRISPR/Cas9 gene targeting technology was used to generate mouse lines with orthologous
mutations; Fmr1CRE and Tenm1CRE (Teneurin transmembrane protein 1). A double-stranded
DNA oligomer that provides a template for the guide RNA sequence was cloned into px461.
The details of guide RNA and repair template sequence are provided in S1 Note in S1 File.
The full gRNA template sequence was amplified from the resulting px461 clone using universal
reverse primer and T7 tagged forward primers. The guide RNA was generated from this PCR
template using T7 RNA polymerase (NEB), and purified with RNeasy mini kit (Qiagen) purifi-
cation columns. The zygotic injection mix contained Cas9 mRNA (Tebu Bioscience @ 50ng/
μl), guide RNA (25ng/μl) and repair template single stranded DNA (IDT 150ng/μl). Injected
embryos were transferred into the oviducts of pseudo-pregnant females to litter down. Geno-
typing of the resulting mice was performed by Sanger sequencing using tail tip DNAs. F0 mice
with desired variant were crossed with C57BL/6 to generate a stable mice line.
In situ hybridization on mouse embryos was performed with DIG-labelled gene-specific
antisense probes as previously described [25]. The sequences of primers used for synthesis of
specific probes are listed in S3 Table in S1 File.
Olfaction test
Male wild-type and Fmr1CRE and Tenm1CRE littermates at P25 were subjected to the buried
food test assay. For three consecutive days before testing ¼ chocolate button (Cadbury) was
placed in the home cage for 15 minutes to habituate the mice to the food reward. 12 hours
before the test, all food was removed from the home cage to motivate the mouse to find the
food reward during the test. After 12 hours, the mouse was placed in a clean cage with fresh
bedding in which ¼ chocolate button had been buried 1cm beneath the bedding. The time
taken to find the buried food was scored and the test was stopped if the mouse did not find the
food after 15 minutes. The bedding was replaced and the cage cleaned with 1% Conficlean
between mice. All mice were scored blind to the genotype. Unpaired t-tests were used to deter-
mine statistical significance.
Seizure propensity testing of Fmr1CRE
Male wild-type and Fmr1CRE littermates at P25 were tested for audiogenic seizures as described
previously [26]. Briefly, animals were transferred to a transparent plastic test chamber and,
after 1 minute of habituation, exposed to a 2 min sampling of a modified personal alarm held
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at> 130dB. Seizures were scored for incidence (seizure/no seizure) and severity, with an
increasing scale of 1 = wild running, 2 = clonic seizure, and 3 = tonic seizure. All mice were
tested and scored blind to genotype. Statistical significance for incidence was determined
using two-tailed Fisher’s exact test.
Basal protein synthesis and FMRP western blotting
Protein synthesis levels were measured following the protocol outlined by Osterweil [27]. The
detailed protocol is described in S2 Note in S1 File.
For western blots, hippocampal slice from P25 male wild-type and Fmr1CRE knock-in
mutant littermates were dissected and homogenized in lysis buffer (20 mM HEPES pH 7.4,
0.5% Triton X-100, 150 mM NaCl, 10% glycerol, 5 mM EDTA with protease inhibitor cocktail
(Roche), incubated at 4˚C for 30 min followed by centrifugation at 14000 rpm for 30 min to
collect the supernatant. These samples were directly used for SDS-PAGE and transferred onto
nitrocellulose membranes for immunoblot analysis with FMR1 antibody (MAB2160, Mili-
pore). Densitometry was performed on scanned blot film using Image Studio Lite software.
Each signal was normalized to total protein in the same blot. Values are shown as a percentage
of average WT for graphical purposes.
Hippocampal slice electrophysiology
Electrophysiology experiments were performed as described [28]. The detailed protocol is
described in S3 Note in S1 File.
RNAseq and RNAscope analysis
In situ RNA hybridization was performed using the RNAscope assay (Advanced Cell Diagnos-
tics, ACD, Hayward, CA, USA) according to the manufacturer’s recommendations. The
detailed protocols described in the S4 Note in S1 File. The images of sections were processed
using the multimodal Imaging Platform Dragonfly (Andor Technologies, Belfast, UK) using
air 40x Plan Fluor 0.75 DIC N2. Data were collected in Spinning Disk 25 μm pinhole mode on
the high sensitivity iXon888 EMCCD camera. According to Advanced Cell Diagnostics, each
mRNA molecule hybridized to a probe appears as separate small puncta. Data visualization
and spot counting was done using IMARIS 8.4 (Bitplane). The details of the RNAseq analysis
are given in S5 Note in S1 File.
Statistical analysis
Statistical analysis was performed using two-tailed Student’s t-test (Prism 4, GraphPad Soft-
ware, La Jolla, CA, USA) except for Fig 6C were significance was determined using two-tailed
Fisher’s exact test (appropriate for analyzing nominal data sets). A p-value of< 0.05 was con-
sidered statistically significant. Data are shown as the mean values ± SE of number of replicates
(n) used in the experiments.
Results
Identifying a cohort likely to be enriched in disease-associated CRE
In a previous study we found that 155/208 families with apparent XLID had no detectable dis-
ease-associated variants in the coding sequence on the X chromosome [16]. We chose affected
male probands from 48 of these undiagnosed families for inclusion in present study. Each
unrelated proband had 3 or more similarly affected relatives with the inheritance pattern being
strongly suggestive of XLID. We reasoned that these families are likely to be enriched for
PLOS ONE Effect of cis-regulatory mutations on gene function
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highly penetrant causative regulatory mutations. In addition, the high prior probability that
any causative variant in these families would be located on the X chromosome significantly
reduced the genomic space for interrogation. A summary of the overall study design is pre-
sented in Fig 1A.
Identifying rare variants in CRE on the X chromosome
We performed targeted sequencing in each proband using a custom 15.9 Mb oligonucleotide
pull-down consisting of 227,323 baits. These baits were designed to capture two non-overlap-
ping sets of target sequences from the human X chromosome (chrX); all chrX coding exons
and all chrX CRE. The set of chrX CRE, accounting for 4.4% of chrX genomic sequence, had
been defined in a previous study [15]. This study also showed that the maintenance of linkage
between a CRE and neighbouring genes throughout evolution was an accurate way to identify
the target gene(s). Target genes assigned using this conserved synteny approach allowed a
maximum CRE to gene distance of 1.5 Mb [15]. Approximately a third of chrX CRE could be
assigned to a single gene with the remainder having>1 equally plausible target. 389/812 pro-
tein coding genes on the X chromosome could be assigned to at least one CRE.
Following sequencing and alignment, a total of 40,699 variant calls passed basic quality con-
trols in these individuals (S1 Fig in S1 File). As expected from our previous work [16], no
likely causative variants were identified in the coding exons. 628 hemizygous variants were
identified in high confidence putative CRE and were not present in the population-based
whole genome sequence data that was available at the time (S1 Fig in S1 File). To further
increase the likelihood of identifying clinically-interpretable variants we focused on the 31/628
altered highly conserved bases in CRE that were predicted to control known XLID genes. 30/
31 were confirmed by Sanger sequence analysis in the probands. 6 of these variants were
shown to segregate appropriately in the XLID families using samples from additional affected,
unaffected males and obligate female carriers (Fig 1B). Details of segregation in available fam-
ily members are shown in S2 Table and S3-S33 Figs in S1 File. 4/48 probands carried one of
these six variants and 1/48 carried two.
FMR1CRE and TENM1CRE CRE variants alter enhancer function in
zebrafish transgenics
The reference and alternative base versions of all six CRE variants were then tested for CRE
function using a dual-color fluorescent transgenic assay in zebrafish [22]. Multiple stable trans-
genic lines were created in which the wild-type and mutant human CRE drives expression of
different fluorescent proteins in the same fish (Figs 2A and 3A). Reporter expression domains
were scored in living embryos between 24 hours and 96 hours post-fertilization (hpf). Only
consistent differences between the reference and alternative alleles in at least 3 independent
lines were taken as evidence of a functional effect of the mutation. The specific criteria for a
variant to be included in future in vivo functional studies were: 1. Strong evidence of variant-
associated disruption of CRE activity in the developing brain. 2. A significant overlap between
the wild-type CRE activity and that of the endogenous neural expression of the orthologous
zebrafish gene (Figs 2C and 3C).
Only two CRE variants in two different probands fulfilled these criteria (Table 2, S34-S39
Figs in S1 File): TENM1CRE (proband S24) and FMR1CRE (proband S3). TENM1CRE showed a
loss of reported expression in the mid- and hind-brain (Fig 2D and 2E). FMR1CRE resulted in
the loss of expression in the forebrain but normal expression in the trigeminal ganglia (Fig 3D
and 3E).
PLOS ONE Effect of cis-regulatory mutations on gene function
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Transcription factor binding site analysis of CRE variants
We next looked at the effect of these CRE variants on putative transcription factor binding
sites. We restricted the analysis to sites that were gained or lost in both the human and mouse
versions of the CRE. The TENM1CRE variant created a novel site predicted to bind SIX3 (SIX
homeobox 3) or SIX6 (SIX homeobox 6) in both the human and orthologous mouse CRE (Fig
2B). SIX3 is essential for early brain development and has pathway-specific activator and
repressor activity [29]. To determine if SIX3-mediated repression may be responsible for the
altered enhancer activity in the variant TENM1CRE we chose to use morpholino-induced
knock-down of endogenous six3 in TENM1WT/TENM1CRE transgenic embryos. The pheno-
typic effect of the morpholinos targeting zebrafish six3 was assessed by 1-cell embryo
Fig 2. TENM1CRE alters enhancer function in the zebrafish brain by creating a repressive SIX3 binding site. (A) A diagrammatic summary of the dual color
fluorescence assay used in this study. The size of the human TENM1 element is provided in the left hand panel in base pairs (bp) (B) Human and mouse
(TENM1CRE/Tenm1CRE) sequences are shown with the variant base marked in blue, resulting in gain of SIX3/SIX6 and HDX binding sites in TENM1CRE and Six6
and Hdx binding sites in Tenm1CRE. (C)mRNA in situ hybridization showing expression of tenm1 in midbrain, hindbrain and neural tube during embryonic
development in wild-type zebrafish. (D-E) Dual color fluorescent transgenic assay in zebrafish with wild-type (Wt) and mutant TENM1CRE driving eGFP and
mCherry expression respectively. Loss of enhancer activity is observed in midbrain and hindbrain with the mutant TENM1CRE allele. Further examples of embryos
for different stable lines are shown in S34 Fig in S1 File. (F-E) six3 knockdown rescues the effect of the mutant variant on the activity of TENM1CRE. Control
morpholino injected embryos show loss of reporter activity in midbrain and hindbrain by mutant allele, where the mutation creates a Six3 binding site (E).
Knockdown of Six3 rescues the activity of mutant allele in the midbrain and hindbrain (F). MB: Midbrain; HB: Hindbrain; NT: Neural tube; hpf: Hours post
fertilization.
https://doi.org/10.1371/journal.pone.0256181.g002
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injections. The amount of morpholino was titrated to the point where there was no morpho-
logical anomaly seen at 24 hours. When this concentration of morpholino was injected into
TENM1WT/TENM1CRE transgenic embryos there was rescue of the activity of mutant CRE in
the midbrain and hindbrain with no effect on the wild-type reporter (Fig 2F and 2G) and
Fig 3. FMR1CRE alters enhancer function in the zebrafish brain. (A) A diagrammatic summary of the dual color fluorescence assay
plasmid constructs used in this study. The size of the human FMR1 element is provided in base pairs (bp) (B) Human and mouse
(FMR1CRE/Fmr1CRE) sequences are shown with the variant base marked in blue, resulting in predicted loss of a RFX2/Rfx2 binding site
in FMR1CRE/Fmr1CRE. (C)mRNA in situ hybridization showing expression of fmr1 in forebrain and midbrain during embryonic
development in wild-type zebrafish. (D-E) Dual color fluorescent transgenic assay in zebrafish with wild-type (Wt) and mutant
FMR1CRE driving eGFP and mCherry expression respectively. Loss of enhancer activity is observed in forebrain with the mutant
FMR1CRE allele. Further examples of embryos for different stable lines are shown in S35 Fig in S1 File. FB: Forebrain; MB: Midbrain;
TG: Trigeminal ganglia; NP: hpf: Hours post fertilization.
https://doi.org/10.1371/journal.pone.0256181.g003
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knockdown of Six3 protein was confirmed by western blotting (S40 Fig and S6 Note in S1
File). This supports the hypothesis that the CRE variant had created a repressive SIX3 binding
site as the mechanism for the transcriptional effect in zebrafish embryos.
The loss of a RFX2 binding site in both human and mouse FMR1/Fmr1 CRE was predicted
with relatively low confidence (Fig 3B). RFX2 (Regulatory factor X2) is a transcription factor
required for spermatogenesis in mice and a wider role in the control of ciliogenesis [30–32].
Given the low confidence of this prediction we did not attempt any functional validation.
Fmr1CRE and Tenm1CRE mouse models
CRISPR/Cas9 induced homologous recombination in mouse zygotes allowed us to individu-
ally “knock-in” the same nucleotide change identified in human FMR1CRE and TENM1CRE
into the orthologous positions in the mouse genome (Fig 1A). We established multiple inde-
pendent mouse lines for each CRE variant on a C57BL/6 background. All lines resulted in via-
ble hemizygous mutant animals, at the expected ratio that were healthy and fertile with no
obvious morphological abnormalities.
Whole-mount in situ hybridization (WISH) with riboprobes targeting either Fmr1 or
Tenm1was used to compare developmental expression patterns between wild-type and mutant
male 13.5 gestational day (GD) embryos. Fmr1CRE caused a significant reduction in Fmr1
expression in the olfactory placodes and the forebrain (Fig 4A and 4B). Fmr1WISH on four
other wild-type and Fmr1CRE embryos is shown in S41 Fig in S1 File. Tenm1CRE did not show
a consistent effect on Tenm1 expression in male embryos at 13.5GD.
To determine if there were measurable phenotypic effects segregating with either CRE vari-
ant we first tested olfaction. This sense was selected for two reasons. First, complete loss of
Fmr1 expression in the olfactory placode in Fmr1CRE embryos was observed. Secondly, muta-
tions in TENM1/Tenm1 have recently been identified in humans and mice associated with
congenital generalized anosmia [33]. Using a buried chocolate button test Fmr1CRE mice
showed a significant increase in time to discovery compared to wild-type male littermates (Fig
5A). Tenm1CRE mice had olfactory function similar to wild-type male littermates (Fig 5B).
Fmr1/FMRP-focused analyses
Loss of FMR1 expression is responsible for Fragile X syndrome, the most common form of
XLID [34]. Although we detected clear differences in Fmr1 expression in embryonic midbrain
and nasal placodes (Fig 4A and 4B and S41 Fig in S1 File), we did not find significant differ-
ence in Fmr1 levels in the post-natal brains of male animals by quantitative RTPCR at postna-
tal day 7 (P7) or P14 (S42 Fig in S1 File). Similarly, at P25 we found no difference in Fmr1
levels in forebrain, midbrain or hindbrain using mRNA sequencing (S43 Fig in S1 File) or in
the ratio of Fmr1:Pax6 transcripts in different regions of the hippocampus using in situ hybrid-
ization with dual-color RNAScope probe sets (Fig 4E and 4F).
Given the gene expression results, we were surprised to find an apparent increase in FMRP
(fragile X mental retardation protein) protein abundance in the hippocampus of Fmr1CRE male
mice compared to wild-type littermates using western blotting (Fig 4G and 4H). We found a
decrease in mGluR-dependent long-term depression (LTD) in the CA3-CA1 hippocampus of
Fmr1CRE males (Fig 6A and 6B). We considered the decrease in LTD to be consistent with the
increased levels of FMRP protein given that an exaggerated LTD is a consistent finding in Fmr1-
null animals [35]. A predisposition to audiogenic seizures is also a consistent phenotype in Fmr1-
null mice but Fmr1CRE male mice showed no increase in such seizures (Fig 6C). The finding of a
significant increase in bulk protein translation levels in the hippocampus of Fmr1CRE male mice
(Fig 6D) was unexpected as this too is considered to be a marker of loss of Fmr1 function [27].
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Re-evaluation of affected individuals within the family in which FMR1CRE is segregating
(Fig 7) revealed no clinical features suggestive of a Fragile X (FRAX) syndrome diagnosis
(OMIM #300624]; FMR1 silencing) other than macrocephaly and intellectual disability.
Importantly none of the individuals carrying FMR1CRE showed signs of FRAX Tremor and
Ataxia Syndrome (FRAXTAS [OMIM #300623]; FMR1 over-expression) [36]. There was no
obvious olfaction anomalies in the affected individuals from this family and no seizure predis-
position. Clinical whole genome sequencing [17] of individual S3 (FMR1CRE proband) did not
identify any other plausible cause of his intellectual disability.
Fig 4. Expression levels of Fmr1 and FMRP in Fmr1CRE. Frontal (A) and saggital (B) views of 13.5GD embryonic
mouse heads following whole-mount in situ hybridization for Fmr1. In each panel the wild-type male embryo is shown
on the left and the Fmr1CRE embryo on the right. There is loss of expression of Fmr1 in the nasal placode and midbrain
Fmr1CRE mutant embryos as compared to wild-type embryos. The Fmr1CRE embryos had been deliberately over-
developed in the chromogenic substrate compared to the wild-type embryos to emphasize the signal difference.
Saggital H&E stained section of whole brain (C) with detailed view (white dashed box) of the hippocampus (D) with
marked hippocampus regions indicating the regions analysed in (F) numbered 1–8, starting from dentate gyrus. (E)
Reference image of RNAscope processed section with Fmr1 transcript (red), Pax6 transcript (green) and nucleus (blue/
DAPI). Each transcript is represented by a spot following the quantitative image processing. (F) Graphical
representation of Fmr1 transcripts normalised to Pax6 transcripts (used as control) between Fmr1CRE (purple)
compared to wild-type littermates (orange) and data represent average of four replicates (n = 4) ±SE. Levels of
significance were determined by 2-tailed Student’s t-test, with p values lower than 0.05 considered statistically
significant. No significant difference was observed in the Fmr1 transcript levels. (G) Western blot of hippocampal
tissue from four Fmr1CRE, four wild-type and two Fmr1-null mice at P25 using an antibody that detects FMRP. (H)
Quantitation of the FMRP bands in (G) indicating an apparent increase in FMRP in Fmr1CRE hippocampal slices. All
quantitative data are presented as mean ±SE and p value of 0.05 or less is considered statistically significant. (� means
difference is statistically significant). FB: Forebrain; MB: Midbrain; NP: Nasal placode; DG: Dentate gyrus.
https://doi.org/10.1371/journal.pone.0256181.g004
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Taken together the data above strongly suggest that Fmr1CRE/FMR1CRE does not result in
simple loss or gain of FMR1 function but rather a complex site and stage specific misregulation
of gene product levels and cellular function.
The impact of gnomAD 2.1 on the interpretation of CRE variants
The release of gnomAD 2.1 in late 2018 [37] represented a very significant change in our
knowledge of the population allele frequencies in the non-coding part of the human genome.
By this point we had already performed our zebrafish dual-colour transgenic screen and
Fig 5. Olfaction testing of Fmr1CRE and Tenm1CRE mouse lines. (A, B) The mice hemizygous for the variant in Fmr1CRE showed a significant increase in time to
discovery compared to wild-type male controls in a buried food test. (C, D) No significant difference in the levels of latency to find food was observed in mice
hemizygous for the variant in Tenm1CRE compared to wild-type littermates. The numbers of animals tested (n) are given in (A) and (C). All quantitative data are
presented as mean ±SE and p value of 0.05 or less is considered statistically significant. (� means difference is statistically significant).
https://doi.org/10.1371/journal.pone.0256181.g005
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created the mouse models for Tenm1CRE and Fmr1CRE. The gnomAD-derived variant allele
frequencies (AF) of the six variants which survived our original filtering are shown in Table 1.
This showed three of the variants remained unique; FMR1CRE, POLA1/PCYT1BCRE (DNA
polymerase alpha 1, catalytic subunit) and KDM6ACRE (Lysine demethylase 6A). However,
TENM1CRE, ARHGEF6CRE (Rac/Cdc42 guanine nucleotide exchange factor 6) and AFF2CRE
(AF4/FMR2 family member 2) were observed in the gnomAD population and the latter two
variants were also seen in hemizygous state suggesting that they were very unlikely to be a
cause of XLID. Although the allele frequency of TENM1CRE was below 1 in 10,000, a frequency
commonly used for clinical filtering of ultrarare variants, we wished to know if this should
change its “plausibly causative” status. Using the approach of Whiffin et al [38] we calculated
the maximum plausible allele frequency (AF) for any XLID causal variant. We chose conserva-
tive parameters: 0.01 for genetic heterogeneity (i.e. 1% of all XLID without a known diagnosis
is caused by variation in a particular CRE), 0.2 for allelic heterogeneity (i.e. only 5 different
causative variants can exist per CRE) and 0.5 for penetrance (this is complicated by X-linked
Fig 6. Functional analysis of FMR1CRE mice. (A) Comparison of mGluR-dependent long-term depression (LTD) in CA3-CA1 components of the
hippocampus of eight Fmr1CRE male mice and eight wild-type male littermates indicates a significant Fmr1CRE-associated decrease in LTD. (B) All
quantitative data are presented as mean ±SE and p value of 0.05 or less is considered statistically significant.(C) No significant difference was
observed in audiogenic seizure incidence in the hemizygous mice with the variant Fmr1CRE(1/21) compared to wild-type littermates(3/9). Statistical
significance is determined using two-tailed Fisher’s exact test and p value of 0.05 or less is considered statistically significant.(D) Significant increase
in bulk protein synthesis levels in slices from dorsal hippocampus of Fmr1CRE knock-in mutant male mice as compared to wild-type male
littermates. Quantitative data is derived from number of biological replicates used (n = 6) in the experiments. Levels of significance were
determined by 2-tailed Student’s t-test, with p values lower than 0.05 considered statistically significant. (� means difference is statistically
significant).
https://doi.org/10.1371/journal.pone.0256181.g006
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inheritance but likely to be ~1 in males and> = 0.1 in females). These parameters gave maxi-
mum permitted 95% confidence AF = 4e06 suggesting that TENM1CRE is not a plausibly cause
of XLID.
Discussion
The motivation for initiating this study was the difficulty in assigning pathogenic or likely
pathogenic status to any de novo or segregating variant in an intergenic regulatory sequence.
Such ultra-rare variants would be almost universally be considered of uncertain significance
using current best practice guidelines for diagnostic interpretation of genomic sequence vari-
ants [39,40]. However functional assays demonstrating that an abnormality gene function
associated with a CRE variant (coded as PS3 in the ACMG guidelines) has the potential to
change many variants of uncertain significance (VUS) to likely pathogenic status [41]. The
question then becomes: how should we use data from functional assays in clinical interpreta-
tion of regulatory variants. Given the rapid switch from targeted whole exome sequencing to
whole genome sequencing, it is likely that there will be an increasing need to develop a rational
approach to the interpretation of ultra-rare regulatory variants.
Here we performed an integrated clinical, genetic, developmental, behavioural and neuro-
physiological approach to the analyses of CRE variants identified in a cohort of affected indi-
viduals that should be enriched for causative cis-regulatory mutations. XLID accounts for
~16% of ID in males [42]. Mutations in the coding region of at least 81 different genes [16,43]
have been identified as causing XLID. Given the significant contribution of XLID to ID and
the observed regulatory variant enrichment in a large cohort of individuals with neurodevelop-
mental disorders [13] we reasoned that we could increase the prior probability of identifying
likely causative mutations by restricting the genomic search space to the X chromosome. We
also chose to limit our investigations to variants in enhancers targeting known XLID genes,
since most of the known disease-associated regulatory mutations were identified because they
partially [44] or fully [45] phenocopy loss-of-function mutations in the target gene. If this were
true for our cohort, then matching the pattern of clinical features of individuals carrying a spe-
cific regulatory mutation to those of the syndrome associated with intragenic mutations would
have diagnostic value.
Fig 7. Family 347 pedigree. Pedigree of Family 347 of which individual S3 is a member showing segregation of the mutation affecting FMR1 expression.
https://doi.org/10.1371/journal.pone.0256181.g007
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Our experimental design can be justified on pragmatic grounds. However, we do recognize
some significant problems with this filtering strategy. First, the CNE variant could induce
expression in cells types where the target gene is normally silenced, which is likely to result in a
phenotype completely distinct from that associated with intragenic mutations. Secondly, if
intragenic mutations in the target gene result in early embryonic lethality this gene would not
be identified as a cause of XLID. However, mutations in a CRE controlling only neural expres-
sion of an essential gene could cause XLID but would be missed in our analysis which is
focussed on known XLID genes. Recently somatic mutations in the brain have been implicated
in the causation of neuro developmental disorders [46]. The fact that we have selected individ-
uals with a positive family history would significantly reduce the prior probability of this dis-
ease mechanism in our cohort. For this reason, we have designed our variant filtering strategy
to identify constitutional mutations and exclude variants that are likely to be mosaic.
In vivo analysis of the enhancer activity using the dual color reporter transgenic zebrafish
embryos proved to be a useful screen. Four CRE (POLA1-PCYT1B, ARHGEF6, KDM6A,
AFF2) showed inconsistent and/or non-specific reporter activity with no difference between
the wild-type and mutant alleles (Table 2). However, this analysis also provided evidence for
abnormal in developmental gene regulation for two CRE controlling FMR1 and TENM1
respectively. For TENM1CRE we could identify the mechanism of the altered reporter gene
expression in zebrafish: de novo formation of a repressive six3 binding site.
It is remarkable that, in absence of obvious homology with human CRE sequences (S44 Fig
in S1 File), the developing zebrafish brain appears to report the same transcription factors to
control site and stage specific gene activation. This argues for a subtler shape-based interaction
of DNA with transcription factors that we are, as yet, unable to understand. Defining the
grammar of this structural effect will significantly aid our interpretation of variants in the non-
coding genome.
The unique CRE variant FMR1CRE is the most plausible disease associated allele of those
identified in this study. This variant produced abnormal embryonic expression of endogenous
Fmr1 in a mouse model (Fig 4A and 4B, S40 Fig in S1 File) consistent with the tissue specific
loss of function during early brain development in the transgenic zebrafish embryos. In con-
trast, we were unable to show evidence of altered transcriptional regulation in the post-natal
brain of Fmr1CRE male mice (Fig 4C–4F). This was particularly interesting given the apparent
increased level of FMRP protein in hippocampal slices derived from P25 Fmr1CRE mice (Fig
4G and 4H). This increase may explain the electrophysiological change of LTD we observed
being the opposite effect to that seen in Fmr1 KO mice. The increase in bulk protein synthesis
was surprising as this effect is seen in Fmr1 KO mice. These apparently paradoxical results are
likely to reflect a complex developmental mis-programming of the cells in the hippocampus.
The results outlined above, provide a clear explanation for why proband S3 and his affected
male relatives carrying FMR1CRE, do not show a clinical pattern typical of either Fragile X syn-
drome [OMIM 300624] or FRAXTAS [OMIM 300623]. The family presented with a non-spe-
cific intellectual disability associated with mild macrocephaly. We consider it likely that many
causative CRE variants be associated with clinical features that differ significantly from those
seen associated with intragenic mutations of target gene. This means that we have relatively
limited ability to predict the phenotypes associated with regulatory mutations even when the
clinical impact of intragenic mutations of target gene are well characterised.
While it remains challenging to recognise causative CRE variants, the availability of popula-
tion-based allele frequencies from whole genome sequencing data has certainly improved our
ability to identify those of likely neutral or low penetrant effect. The gnomAD 2.1 data allowed
us to show that TENM1CRE was implausible as an XLID causative variant despite it being in an
evolutionarily conserved, non-redundant CRE with a strong repressive effect in the zebrafish
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transgenic analyses. Filtering for extreme rarity of individual alleles will aid the identification
of causative variants in CRE that are under high levels of selective constraint within human
populations [47]. However, human genetic filtering will have to be supported by strong, multi-
source, disease-relevant functional data before a likely causative status can be assigned to any
CRE variant.
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